Scroll To Top
Search by Speciality

Next Gen Immuno-Oncology Congress 2018

From 499 to 1499 USD
Event Preview
This event
is Finished
Title: Next Gen Immuno-Oncology Congress 2018
Specialty: Radiation Oncology
Dates: From Jun, 21, 2018 to Jun, 22, 2018
Location: Seattle, USA
Type: Congress
Registration Cost: From 499 to 1499 USD
Event Tools
  • Add to Favorites
  • Claim this event
Add to my Calendar
  • Scientific Programm
  • Online registration
  • Exhibition floorplans
  • Sponsorship &
    Exhibition consensus
  • Virtual Booths
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for Seattle, Usa.
General Info
Event Venue:


Seattle, USA Visit the Venue to read more
Concerned Audience:
  • Medical_Professionals
  • Medical_students
  • Nurses
Event Overview
Welcome message:

The next big question in cancer immunotherapy is what’s next in immune-oncology? Overcoming resistance to various combinatorial approaches, selecting the patients and developing translational hypothesis besides designing optimal preclinical models for immunological agents, different strategies to regulate the microbiome are some of the major challenges faced by cancer research experts in the US.

There have been remarkable advancements in cancer immunotherapy especially in the clinical development of immune checkpoint inhibitors, neoantigen-based immunotherapy and microbiome-derived immunotherapy in cancer. One of the most promising approach in terms of ACT (Adoptive Cell Transfer) is the CAR-T cell therapy which has recently received its second approval from the FDA.

Following the success of our UK Edition, MarketsandMarkets is proud to announce the Next Gen Immuno-Oncology Congress-US Edition to be held on 21st and 22nd June 2018 in Philadelphia, USA. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to address the latest updates in development of CAR-T cell therapy, neoantigen-based and microbiome-derived immunotherapy and new paradigms in immune checkpoint inhibitors. This congress would also focus on various combination strategies, pre-clinical and translational immune-oncology developments, updates in cellular and viral therapies, vaccines development and personalized immunotherapy. Keynote presentations, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced and come up with solutions.


Stephen Schoenberger

Professor of Immunology, La Jolla Institute for Allergy and Immunology, San Diego, USA


Neil Sheppard

Director, Head External Cooperations & Early Development Leader, Oncology Cell Therapy, GSK, Philadelphia, USA


Laura Johnson

Senior Director, Head Translational Medicine, Oncology Cell Therapy, GSK, Philadelphia, USA


Rakesh Dixit

Vice President, R&D, MedImmune, USA

Registration Needs updating Register Now


Registration Cost
Early Registration

Late Registration From: 2018-01-08 To: 0--
On site Registration
Academic Delegate
Industry Delegate
Solution Provider Delegate

Group Registrations:

Group registrations not allowed

Accompanying Persons:

Accompanying persons not allowed

Registration Documents:
Letter of invitation:
We don’t provide letter of invitation
Letter of confirmation:
We don’t provide Letter of Confirmation
Proof of professional / educational status:
We don’t need Proof of professional/educational status
Online Abstract Submission:

We don’t accept Online Abstracts

Scientific Content Up to Date
Submission Info

All Poster presentations will take place in breaks and alongside the breakout sessions of the congress.  All the presentation will be displayed in a dedicated area along with accepted posters from both industry & vendor delegates.

To present a poster the presenter should be registered as a delegate and the poster space will be assigned on a first come first basic (Subjected to successful registration & space availability)In order to present a poster at the forum you need to be registered as a delegate.

Please note that there is limited space available and posters space is assigned on a first come first served basis (subject to checks and successful registration).

Posters should be presented as A0 or US equivalent, size E (841mm x 1189mm or 34 x 44 inches respectively) in portrait orientation.

Poster presentations are available to registered delegates only.

For further details and requirements please contact:


Sponsors Exhibitors
General Info

Contact No.: +44 (0)1865-842-976


Organising Agency

Contact No.: +44 (0)1865-842-976


Event map
Revelant Events